ATE477272T1 - Verwendung von stefin a als gerüstprotein - Google Patents

Verwendung von stefin a als gerüstprotein

Info

Publication number
ATE477272T1
ATE477272T1 AT06744166T AT06744166T ATE477272T1 AT E477272 T1 ATE477272 T1 AT E477272T1 AT 06744166 T AT06744166 T AT 06744166T AT 06744166 T AT06744166 T AT 06744166T AT E477272 T1 ATE477272 T1 AT E477272T1
Authority
AT
Austria
Prior art keywords
stefin
scaffold
mutations
relates
leu73
Prior art date
Application number
AT06744166T
Other languages
English (en)
Inventor
Robbie Woodman
Johannes Yeh
Sophie Laurenson
Ferrigno Paul Ko
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0511873A external-priority patent/GB0511873D0/en
Priority claimed from GB0608836A external-priority patent/GB0608836D0/en
Application filed by Medical Res Council filed Critical Medical Res Council
Application granted granted Critical
Publication of ATE477272T1 publication Critical patent/ATE477272T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1044—Preparation or screening of libraries displayed on scaffold proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06744166T 2005-06-10 2006-06-08 Verwendung von stefin a als gerüstprotein ATE477272T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0511873A GB0511873D0 (en) 2005-06-10 2005-06-10 Scaffold
GB0608836A GB0608836D0 (en) 2006-05-04 2006-05-04 Scaffold
PCT/GB2006/002115 WO2006131749A2 (en) 2005-06-10 2006-06-08 Scaffold

Publications (1)

Publication Number Publication Date
ATE477272T1 true ATE477272T1 (de) 2010-08-15

Family

ID=37314237

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06744166T ATE477272T1 (de) 2005-06-10 2006-06-08 Verwendung von stefin a als gerüstprotein

Country Status (9)

Country Link
US (2) US8063019B2 (de)
EP (1) EP1904529B1 (de)
JP (1) JP4989638B2 (de)
AT (1) ATE477272T1 (de)
AU (1) AU2006256530B2 (de)
CA (1) CA2610976C (de)
DE (1) DE602006016133D1 (de)
DK (1) DK1904529T3 (de)
WO (1) WO2006131749A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006016133D1 (de) * 2005-06-10 2010-09-23 Medical Res Council London Verwendung von stefin a als gerüstprotein
GB0807065D0 (en) 2008-04-18 2008-05-21 Univ Leeds Novel scaffolds
GB201302597D0 (en) 2013-02-14 2013-04-03 Univ Leeds Novel Synthetic Proteins
WO2015196070A1 (en) * 2014-06-20 2015-12-23 Genentech, Inc. Chagasin-based scaffold compositions, methods, and uses
US20210206818A1 (en) 2016-01-22 2021-07-08 Modernatx, Inc. Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereof
PL3565905T3 (pl) 2017-01-04 2022-09-26 Mgi Tech Co., Ltd. Sekwencjonowanie kwasów nukleinowych z zastosowaniem odczynników powinowactwa
WO2018211126A1 (en) 2017-05-19 2018-11-22 Philip Morris Products S.A. Diagnostic test for distinguishing the smoking status of a subject
GB201710973D0 (en) * 2017-07-07 2017-08-23 Avacta Life Sciences Ltd Scaffold proteins
AU2020367510A1 (en) * 2019-10-16 2022-06-02 Lg Chem, Ltd. Neonatal Fc receptor binding AFFIMERs
GB202101299D0 (en) 2020-06-09 2021-03-17 Avacta Life Sciences Ltd Diagnostic polypetides and methods
WO2023182945A2 (en) * 2022-03-24 2023-09-28 Agency For Science, Technology And Research Engineering peptides using peptide epitope linker evolution
WO2024141788A1 (en) * 2022-12-29 2024-07-04 Affyxell Therapeutics Co., Ltd. Genetically modified stem cells expressing exogenous binding agents and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2182598C2 (ru) * 1994-11-21 2002-05-20 Новартис Аг Модифицированные ингибиторы протеиназы
NZ509013A (en) * 1998-07-20 2002-12-20 Inoxell As Novel methods for the identification of ligand and target biomolecules
US20080113917A1 (en) * 2003-11-06 2008-05-15 Day Anthony G Tgfbeta Supported and Binding Peptides
DE602006016133D1 (de) * 2005-06-10 2010-09-23 Medical Res Council London Verwendung von stefin a als gerüstprotein

Also Published As

Publication number Publication date
US8063019B2 (en) 2011-11-22
EP1904529B1 (de) 2010-08-11
DK1904529T3 (da) 2010-11-15
CA2610976A1 (en) 2006-12-14
JP2008541776A (ja) 2008-11-27
US20080207509A1 (en) 2008-08-28
DE602006016133D1 (de) 2010-09-23
AU2006256530B2 (en) 2012-12-20
US20120190819A1 (en) 2012-07-26
CA2610976C (en) 2020-11-24
JP4989638B2 (ja) 2012-08-01
EP1904529A2 (de) 2008-04-02
US8481491B2 (en) 2013-07-09
AU2006256530A1 (en) 2006-12-14
WO2006131749A3 (en) 2007-05-18
WO2006131749A2 (en) 2006-12-14

Similar Documents

Publication Publication Date Title
ATE477272T1 (de) Verwendung von stefin a als gerüstprotein
ATE540111T1 (de) Hla-dr-bindendes antigenpeptid, das von wt1 abgeleitet ist
DK1844150T3 (da) Rekombinant ekspression af proteiner i en to-kædet form med disulfidbroer
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
ATE482972T1 (de) Tgf-beta1-bindende und geträgerte peptide
Claeys et al. Multiple gene duplication in the evolution of plasminogen. Five regions of sequence homology with the two internally homologous structures in prothrombin
DK1194560T3 (da) Antigene Neisseria-peptider
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
DE60230456D1 (de) Faktor-viii-polypeptide auf hohem expressionsnivea und verwendungsverfahren
DK1530637T3 (da) Carlsberg-subtilisin-proteiner med nedsat immunogenitet
ATE500266T1 (de) Methode zur verbesserung der wirksamkeit von biologischen antwort-verändernden proteinen und exemplarische muteine
DE602004015142D1 (de) Antiangiogene peptide zur behandlung oder vorbeugung von endometriose
WO2007013358A3 (en) Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent
IL173954A0 (en) Libraries of recombinant chimeric proteins and methods of generating the same
DE60028248D1 (de) Methode zur reduzierung der immunogenizität von staphylokinase durch entfernen von t-zell epitopen
ATE538806T1 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
ATE466876T1 (de) Immunogene konstrukte
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
DK2186898T3 (da) Blomstrings-induktion
ATE423200T1 (de) Neues plexin-polypeptid, dieses codierende dna und verwendung davon
DE602004008081D1 (de) Verfahren zum spalten von proteinen
NZ603077A (en) Biological materials and uses thereof
ATE529437T1 (de) Verfahren zur sauerstoff-regulierten produktion von recombinanter staphylokinase

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1904529

Country of ref document: EP